A cluster-randomized controlled trial testing the effectiveness of the Life Enhancing Alcohol-management Program (LEAP) for Housing First residents
一项整群随机对照试验,测试住房第一居民的生活改善酒精管理计划 (LEAP) 的有效性
基本信息
- 批准号:10116236
- 负责人:
- 金额:$ 61.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-05-20 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAccident and Emergency departmentAddressAffectAlcohol consumptionAlcoholsChronicClientCommunitiesCriminal JusticeDevelopmentDoseEmergency CareEmergency medical serviceEvaluationFundingHarm ReductionHealthHealthcareHomelessnessHousingIndividualInterventionJailLeadershipLifeMediator of activation proteinMedicalMorbidity - disease rateNeeds AssessmentNoiseOutcomeParticipantPathway interactionsPilot ProjectsPoliciesPopulationPositioning AttributeProcessProgram EffectivenessProgram EvaluationPublic HealthQuality of lifeRandomizedRandomized Controlled TrialsRecoveryReportingResearchResearch PersonnelRoleServicesSiteSubstance Use DisorderTestingTimeUrsidae FamilyUse EffectivenessVulnerable PopulationsWorkalcohol abstinencealcohol abuse therapyalcohol related problemalcohol use disorderarmattributable mortalitybasecommunity based participatory researchcosteffectiveness testingepidemiologic dataevidence baseexperienceflexibilityfollow up assessmentfollow-uphigh risk drinkingimprovedinnovationinterestintrinsic motivationmarginalized populationpatient engagementpersonalized approachphysical assaultprogramspublic health relevancereduced alcohol useresponseservice utilizationservices as usualsexual assaultsocialstemsubstance usesupported housing
项目摘要
PROJECT SUMMARY/ABSTRACT
People experiencing chronic homelessness comprise a small yet high-morbidity, high-cost subset of the
larger homeless population and are disproportionately impacted by alcohol-related harm. Unfortunately,
traditional abstinence-based treatment does not adequately reach or engage this population, and both
firsthand (problems stemming from one’s own alcohol use) and secondhand (problems stemming from others’
alcohol use) alcohol-related harm persists even after housing attainment. There have therefore been calls for
more flexible and client-centered approaches tailored to this population’s needs. Housing First, which entails
the provision of immediate, permanent, low-barrier, nonabstinence-based housing, is a response to this call.
Research has shown that Housing First is associated with decreased alcohol use, alcohol-related harm, and
publicly funded service utilization. Nonetheless, Housing First residents continue to experience both first- and
secondhand alcohol-related harm. Thus, further community-based interventions are necessary. To this end,
a pilot project was conducted in which researchers as well as Housing First residents, staff and management
codeveloped, implemented, and initially evaluated the Life Enhancing Alcohol-management Program (LEAP).
The LEAP entails low-barrier, community-level, house-wide resident programming—including leadership
opportunities, activities, and pathways to recovery. At the 6-month follow up, LEAP participants reported
significantly more engagement in meaningful activities than control participants (p < .001). Moreover, high
levels of LEAP program engagement (>2 activities per month) predicted significant reductions in alcohol use
and alcohol-related harm (ps < .01). To build on these promising findings, we propose a larger, cluster-
randomized controlled trial of LEAP (N=500) as an innovative, community-based, and client-driven adjunct
to Housing First. In the proposed project, 10 Housing First sites will be optimally matched and block
randomized on a rolling basis to either LEAP or services-as-usual control conditions. At LEAP sites, research
staff will work with housing staff and residents to conduct a needs assessment, form a community advisory
board, and develop and implement this community-level intervention. Participants in the LEAP evaluation will
meet criteria for at-risk drinking and will be assessed at baseline, 3-, 6-, and 12-month follow-ups. Analyses
will test LEAP effectiveness in increasing engagement in meaningful activities, decreasing alcohol use,
ameliorating both first- and secondhand alcohol-related harm, and improving quality of life. Engagement in
meaningful activities will also be tested as a mediator of the LEAP effect on alcohol and quality-of-life
outcomes. Finally, we will assess whether LEAP is associated with reduced costs stemming from participants’
use of emergency health-care and criminal justice services.
项目概要/摘要
经历长期无家可归的人只占人口中发病率高、成本高的一小部分。
不幸的是,更多的无家可归者受到酒精相关伤害的影响。
传统的基于禁欲的治疗无法充分接触或吸引这一人群,而且
第一手(因自己饮酒而产生的问题)和二手(因他人饮酒而产生的问题)
即使在获得住房后,酒精相关的危害仍然存在,因此有人呼吁。
针对这一人群的需求采取更灵活、以客户为中心的方法,这需要采取住房优先的措施。
提供直接、永久、低门槛、非禁欲住房就是对这一呼吁的回应。
研究表明,住房优先与减少饮酒、酒精相关伤害以及
尽管如此,住房优先居民仍继续体验优先和公共资助的服务。
因此,有必要采取进一步的社区干预措施。
开展了一个试点项目,研究人员以及住房第一居民、工作人员和管理人员
共同开发、实施并初步评估了生活改善酒精管理计划 (LEAP)。
LEAP 需要低门槛、社区层面、全屋居民规划——包括领导力
LEAP 参与者在 6 个月的随访中报告了恢复的机会、活动和途径。
与对照组参与者相比,他们明显更多地参与有意义的活动 (p < .001)。
LEAP 计划参与水平(每月 > 2 项活动)预测酒精使用量将显着减少
为了建立在这些有希望的发现的基础上,我们提出了一个更大的集群。
LEAP 的随机对照试验 (N=500) 作为一种创新、基于社区和客户驱动的辅助手段
在拟议的项目中,将优化匹配和封锁 10 个“住房第一”用地。
在 LEAP 站点、研究中滚动随机分配至 LEAP 或照常服务控制条件。
工作人员将与住房工作人员和居民合作进行需求评估,形成社区咨询
董事会,并制定和实施这一社区级干预措施。 LEAP 评估的参与者将。
符合危险饮酒标准,并将在基线、3、6 和 12 个月的随访分析中进行评估。
将测试 LEAP 在增加有意义的活动参与度、减少饮酒、
改善与第一手和二手酒精相关的伤害,并提高生活质量。
有意义的活动也将作为 LEAP 对酒精和生活质量影响的中介进行测试
最后,我们将评估 LEAP 是否与参与者的成本降低有关。
使用紧急医疗保健和刑事司法服务。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Seema Lisa Clifasefi其他文献
Seema Lisa Clifasefi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Seema Lisa Clifasefi', 18)}}的其他基金
Social-Ecological Resilience: Adapting a Measure for Individuals with Lived Experience of AUD and Homelessness.
社会生态复原力:针对有澳元和无家可归经历的个人采取措施。
- 批准号:
10402620 - 财政年份:2021
- 资助金额:
$ 61.23万 - 项目类别:
A cluster-randomized controlled trial testing the effectiveness of the Life Enhancing Alcohol-management Program (LEAP) for Housing First residents
一项整群随机对照试验,测试住房第一居民的生活改善酒精管理计划 (LEAP) 的有效性
- 批准号:
10578691 - 财政年份:2019
- 资助金额:
$ 61.23万 - 项目类别:
A cluster-randomized controlled trial testing the effectiveness of the Life Enhancing Alcohol-management Program (LEAP) for Housing First residents
一项整群随机对照试验,测试住房第一居民的生活改善酒精管理计划 (LEAP) 的有效性
- 批准号:
10357932 - 财政年份:2019
- 资助金额:
$ 61.23万 - 项目类别:
A cluster-randomized controlled trial testing the effectiveness of the Life Enhancing Alcohol-management Program (LEAP) for Housing First residents
一项整群随机对照试验,测试住房第一居民的生活改善酒精管理计划 (LEAP) 的有效性
- 批准号:
10529057 - 财政年份:2019
- 资助金额:
$ 61.23万 - 项目类别:
Development of LEAP for the Homeless with Alcohol Problems
为有酗酒问题的无家可归者开发 LEAP
- 批准号:
8440268 - 财政年份:2013
- 资助金额:
$ 61.23万 - 项目类别:
Development of LEAP for the Homeless with Alcohol Problems
为有酗酒问题的无家可归者开发 LEAP
- 批准号:
9000079 - 财政年份:2013
- 资助金额:
$ 61.23万 - 项目类别:
Development of LEAP for the Homeless with Alcohol Problems
为有酗酒问题的无家可归者开发 LEAP
- 批准号:
9210029 - 财政年份:2013
- 资助金额:
$ 61.23万 - 项目类别:
Development of LEAP for the Homeless with Alcohol Problems
为有酗酒问题的无家可归者开发 LEAP
- 批准号:
8817220 - 财政年份:2013
- 资助金额:
$ 61.23万 - 项目类别:
相似海外基金
An Enzyme-Based Antidote for Acute Nicotine Toxicity
一种基于酶的急性尼古丁中毒解毒剂
- 批准号:
10790758 - 财政年份:2023
- 资助金额:
$ 61.23万 - 项目类别:
A multi-team system implementation strategy to improve buprenorphine adherence for patients who initiate treatment in the emergency department
多团队系统实施策略,以提高在急诊科开始治疗的患者的丁丙诺啡依从性
- 批准号:
10740793 - 财政年份:2023
- 资助金额:
$ 61.23万 - 项目类别:
Transporting treatment effects from clinical trials to real-world populations with co-occurring opioid and stimulant use disorders
将临床试验的治疗效果转移到同时发生阿片类药物和兴奋剂使用障碍的现实人群中
- 批准号:
10526149 - 财政年份:2022
- 资助金额:
$ 61.23万 - 项目类别:
Ketamine for the treatment for alcohol use disorder in the emergency department: A pilot double-blind, placebo-controlled randomized clinical trial
氯胺酮在急诊科治疗酒精使用障碍:一项双盲、安慰剂对照随机临床试验
- 批准号:
10593244 - 财政年份:2022
- 资助金额:
$ 61.23万 - 项目类别:
Effect of methadone on the developmental properties of human brain organoids
美沙酮对人脑类器官发育特性的影响
- 批准号:
10442944 - 财政年份:2022
- 资助金额:
$ 61.23万 - 项目类别: